XML 64 R55.htm IDEA: XBRL DOCUMENT v3.24.3
Business Segment Information - Summary of EBIDTA by Reporting Segment (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Segment Reporting Information [Line Items]        
Adjusted EBITDA $ 30,066 $ 23,070 $ 76,331 $ 59,218
Corporate operating expenses 10,886 9,549 32,853 32,574
Interest expense, net 5,210 1,576 14,711 4,131
Depreciation and amortization 15,173 13,097 44,067 39,094
Share-based compensation expense 6,531 6,274 25,290 32,540
Foreign exchange impact (1,176) 1,909 1,263 1,057
SeaSpine merger-related costs 2,616 5,416 12,992 34,362
Strategic investments 39 484 470 1,454
Acquisition-related fair value adjustments 5,017 7,122 15,351 26,907
Interest and loss on investments 3,567 429 5,120 429
Litigation and investigation costs 8,335 3,851 10,318 5,611
Succession charges 505 (92) 8,061 170
Medical device regulation   1,840   7,519
Loss before income taxes (26,637) (28,385) (94,165) (126,630)
Operating Segments [Member] | Global Spine [Member]        
Segment Reporting Information [Line Items]        
Adjusted EBITDA 26,795 22,593 74,373 58,832
Operating Segments [Member] | Global Orthopedics [Member]        
Segment Reporting Information [Line Items]        
Adjusted EBITDA $ 3,271 $ 477 $ 1,958 $ 386